Other
abstention
abstention is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting267%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
Risk Factors and Progression of Keratoconus
NCT05676580
recruitingnot_applicable
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
NCT06338215
completednot_applicable
Pragmatic Clinical Trial of Two Recommendations Regarding Alcohol Consumption: a Pilot Study NAMETI_ALCOHOL
NCT06214416
Clinical Trials (3)
Showing 3 of 3 trials
NCT05676580Not Applicable
Risk Factors and Progression of Keratoconus
NCT06338215Not Applicable
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
NCT06214416Not Applicable
Pragmatic Clinical Trial of Two Recommendations Regarding Alcohol Consumption: a Pilot Study NAMETI_ALCOHOL
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3